Modalis Therapeutics Reports Positive Foreign Exchange Gains
Company Announcements

Modalis Therapeutics Reports Positive Foreign Exchange Gains

Modalis Therapeutics Corporation (JP:4883) has released an update.

Modalis Therapeutics Corporation has reported a non-operating income of 19 million yen due to favorable foreign exchange rate fluctuations for the first nine months of 2024. This reflects positively on the company’s financial performance, showcasing effective management of foreign currency assets and liabilities.

For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App